Health Condition 1: null- Symptoms and Signs of Diabetic Polyneuropathy
Conditions
Interventions
Intervention1: Homoeopathic Constitutional medicines- Arsenic album, Calcarea carbonica, Carbo vegetabilis, Conium maculatum, Kali carbonicum, Lycopodium clavatum, Phosphorus, Pulsatilla nigricans, Pl
Sponsors
Central Council for Research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: Both sexes of age between 30-70 years. Diagnosed cases of Type 2 Diabetes stable with allopathic treatment for last 3 months. DNE >= 3 Abnormal Nerve conduction test. HbA1C Controlled Hypertension Written Informed consent from the patient.
Exclusion criteria
Exclusion criteria: i. Diabetic Mononeuropathy ii. Diabetic Polyradiculopathy iii. Diabetic amyotrophy iv. Diabetic Autonomic Neuropathy v. Abnormalities of gait vi. Development of typical Charcotâ??s joints, particularly in the feet vii. Loss of arch with multiple fractures of tarsal bones viii. Wrist drop ix. Foot drop x. Paralysis of III, IV or VI Cranial Nerves xi. Myocardial infarction less than 6 months xii. Unstable angina xiii. Neuropathy due to other causes e.g. Vitamin B12 deficiency. xiv. Alcohol addiction or dependence xv. Cases presenting with long term complication of diabetes such as severe retinopathy, severe renal involvement or with history of recurrent acute complications like hypoglycemia, ketoacidosis, polyneuropathy etc. xvi. Subjects with ill managed diabetes i.e. glycosylated hemoglobin (HbA1c) more than 8% xvii. Cases with other systemic diseases like cardiovascular, endocrinal diseases like thyroid dysfunction or Systemic infections or on other treatment therapies. (except for hypertensive and dyslipedemic patients on standard care)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the NTSS â?? 6Timepoint: Change in the NTSS â?? 6 from baseline to 12 months post intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ To compare the changes in Serum glycosylated haemoglobinTimepoint: 3rd, 6th, 9th and 12th months between the groups;Change in Diabetic Neuropathy Examination ScoreTimepoint: 12 months;To compare the changes in WHOQOL BREFTimepoint: baseline 3rd, 6th, 9th and 12th month;To compare the Peripheral nerve conduction test and lipid profileTimepoint: 6 and 12 months between the groups | — |
Countries
India
Contacts
Public ContactDr Bindu Sharma
Central Council for Research in Homoeopathy
Outcome results
None listed